Concordance of different PD-L1 assays: expression in bladder and kidney cancer
Tian Zhang • 15 Feb 2019
Characterization of circulating immune cells in metastatic urothelial cancer following treatment
Updates on MRx0518 + pembro in patients with resistance to therapy
Alex Stevenson • 27 Nov 2020
Optimising treatment for advanced urothelial cancer: combination, maintenance or sequencing?
Arlene Siefker-Radtke • 14 Oct 2020